*This content was translated by AI.
Hanwha Life Insurance announced that it has achieved about 36,000 cumulative subscriptions within two months of launching a "Carty Life Surgery Special" that guarantees self-stem cell-based knee joint regeneration treatment.
The special agreement was granted exclusive use rights for six months by the Life Insurance Association. The collateral that has acquired exclusive use rights is not high as it is a new guarantee that did not exist before, but half of the subscribers chose this special contract.
This is about four times higher than the initial addition rate (about 10%) of major special agreements, such as the Special Agreement to Support Cancer Testing Cost and the Special Agreement to Guarantee Cancer Multidisciplinary Integrated Medical Care, which Hanwha Life recently acquired exclusive use rights.
This special agreement is the first in the industry to guarantee self-stem cell-based knee cartilage regeneration surgery. Exclusive use rights were granted in recognition of structuring new medical technologies as collateral and quantifying related risks, which were not guaranteed by existing insurance products.
Hanwha Life also focused on easing the cost burden on the latest regenerative treatments. CartiLife surgery is a treatment that is gradually expanding in the medical field, but the average treatment cost is about 15 million won, which is not small.
Among the special contract subscribers, the proportion of those in their 50s and 60s was close to 80%. It is analyzed that the demand of middle-aged people to preserve joint function in the pre-artificial joint surgery stage is concentrated, and interest in regenerative treatment has led to actual subscription.
The special agreement is sold on Signature H Integrated Health Insurance. If you have undergone Carty Life surgery during the insurance period, you will pay insurance money only once for the first time.
An official from Hanwha Life Insurance, who spoke to this newspaper by phone, said, "Recently, the medical field has been changing from the center of artificial joint replacement to the center of cartilage regeneration and joint preservation."
<© STARNEWS. All rights reserved. No reproduction or redistribution allowed.>
*This content was translated by AI.
